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Abstract 
After passage of the 21st Century Cures Act, NIH held a workshop in 2017 to consider 
expanding its inclusion policy to encompass individuals of all ages. AGS leaders and members 
participated in the workshop and formal feedback period. AGS advocacy clearly impacted the 
resulting workshop report and Inclusion Across the Lifespan policy, which eliminates upper age 
limits for research participation unless risk-justified, and changes the language used to describe 
older adults and other vulnerable groups. AGS recommendations that were not specifically 
stated in the updated policy were to encourage active recruitment of older adults, add standard 
measures of function and/or frailty, and changes to review criteria to ensure that the health 
status of a study population mirrors typical clinical populations. Ultimately, the updated inclusion 
policy offers academic geriatrics opportunities to expand knowledge about health in aging and 
to continue to provide leadership for research and advocacy efforts on behalf of older adults.   
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Introduction  
Over the past three decades, the National Institutes of Health (NIH) has instituted 
policies to provide specific guidance regarding research participant inclusion, with the goal of 
ensuring NIH-funded research reflects affected populations living with conditions under study. 
Historically, other federal agencies funding research relevant for the U.S. population adopt NIH 
inclusion policies. Initially, NIH inclusion policies focused on inclusion of women and minority 
populations. Subsequently, updates were implemented to support inclusion of children. Most 
recently, the passage of the 2016 21st Century Cures Act required that the NIH convene a 
workshop to consider expanding its inclusion policy to include individuals of all ages.1 In the 
summer of 2017, American Geriatrics Society (AGS) leaders and members representing a 
range of aging-research expertise participated in an NIH workshop focused on an updated 
Inclusion Across the Lifespan policy.2 Workshop presentations highlighted that older people and 
children are often excluded from clinical research studies, sometimes without a strong scientific 
or ethical rationale.3,4 AGS participation in the workshop and formal feedback following a 
request for information clearly influenced the resulting Inclusion Across the Lifespan policy and 
workshop report, both published in December 2017.3,5 In this article, we provide details about 
AGS engagement in the process that led to this policy change and to the integration of the 
recommendations for reframing aging into the conference report and broader next steps.6 We 
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also propose strategies that AGS members and academic geriatrics programs should consider 
to support better representation of older adults in clinical research and to integrate geriatrics 
expertise into future clinical trials. A companion manuscript included in this issue presents new 
data from program staff at the National Institute on Aging (part of the NIH), which further 
highlights gaps in representing older adults in NIH-funded clinical research related to conditions 
that disproportionately affect us all as we age.7 
 
 
Summary of the Inclusion Across the Lifespan Policy 
The new Inclusion Across the Lifespan policy, which impacts all NIH proposals or 
competing renewals with due dates starting January 25, 2019, will eliminate arbitrary age limits. 
Previous guidance required justification for the inclusion or exclusion of children. Investigators 
will now be asked to provide a scientific justification for excluding older adults on the basis of 
age. 
The new policy also includes potentially acceptable reasons to exclude certain age 
groups. For instance, it is appropriate to exclude age groups in whom a disease does not occur 
or for whom knowledge regarding the scientific question is already available. Understandably, if 
the study will collect or analyze data on pre-enrolled study participants, such as those in an 
existing cohort study, then participants from across the lifespan will not be available. In some 
cases, an age-specific study in a previously excluded age group is warranted and preferable. 
Adherence to the new policy will be assessed during scientific review, with review panels 
determining whether inclusion/exclusion criteria because of age are ‘acceptable’ or 
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‘unacceptable.’ Assessment of whether the proposed age range is reasonable for the scientific 
goals of the study may also factor into the priority score given for an application. If reviewers 
determine that an application has unacceptable inclusion/exclusion criteria, the policy states that 
the study will not be funded until this issue is resolved. 
 
Summary of NIH Implementation of the Policy Change  
Federal Law required consideration of policy changes related to inclusion across the 
lifespan within 180 days of the workshop, resulting in rapid adoption by the NIH. Staff training 
has been completed with all Review Officers and Program Officers. NIH is providing training for 
investigators regarding the inclusion policy as part of its general outreach during NIH regional 
seminars, professional society meetings, and other standard NIH training. In addition, NIH 
leaders are preparing a summary article outlining the history of NIH inclusion policies and 
expectations for this new policy.  
To facilitate monitoring inclusion enrollment for human subject research, the NIH 
changed its “Inclusion Management System” to a new Human Subjects System (HSS). HSS 
allows the submission of anonymized individual level data on subjects in ongoing studies. Such 
submissions will become mandatory in progress reports for projects submitted and funded 
starting January 25, 2019. Pertinent information regarding the HSS can be accessed 
at https://era.nih.gov/hss_overview.cfm and https://era.nih.gov/hss_training.htm. Briefly, grant 
recipients can view/edit/update existing enrollment data, create new enrollment reports, and 
make off-cycle corrections or updates using this system, entered through eraCommons. In the 
future, researchers will be able to use data from the Human Subjects system to initiate and 
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populate a ClinicalTrials.gov registration. Users will be required to upload participant-level data 
using a standardized report form so age-specific inclusion can be monitored more easily. 
Investigators are reminded to include language during the informed consent to transmit 
deidentified, individual data on sex/gender, race, ethnicity and age at enrollment to NIH (given 
limited numbers those ≥ 90-years-old will be reported in aggregate to protect confidentiality). 
Program Officers will conduct inclusion enrollment reviews at least yearly at the time of progress 
report, and can request more frequent reviews if concerns are noted. Training for investigators 
is available on accessing and using the new reporting system.  
Since the new policy encompasses all of NIH, there are no planned changes to inclusion 
language in specific Funding Opportunity Announcements (FOAs). However, there are 
upcoming changes to review criteria in FOAs related to the policy 
(https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-228.html). Language in the reviewer 
package was changed to define “older adults” using AGS-advocated terminology. An FOA for 
applications related to the science of recruitment across the lifespan was open at the time of this 
article’s publication.8 It is not yet clear how the policy will be viewed and enforced by reviewers 
in actual practice; this remains an area the NIH will monitor closely. 
 
AGS Advocacy Related to NIH Inclusion Across the Lifespan Policy and Workshop 
Report 
During the workshop and in formal comments following the workshop, AGS advocated for: 
− Eliminating upper age limits for participants unless risk-justified: Exclusion of trial participants 
based on arbitrary upper-age restrictions complicates further research and clinical practice in 
 
 
This article is protected by copyright. All rights reserved.
 Inclusion Across the Lifespan 
several key ways. Upper age limit exclusions lead to studies that fail to analyze outcomes for 
some of the people most likely to experience a disease or condition. Thereby, these studies 
result in evidence not applicable to the population living with a condition. AGS 
representatives advocated that exclusion criteria should only limit involvement of older adults 
with a significant health risk associated with participation. Guidance from the final Inclusion 
Across the Lifespan policy focuses on developing realistic inclusion/exclusion criteria so that 
participants with comorbidities or physical/cognitive limitations common in the study 
population still can be represented in research and its findings. 
− Changing the language used to describe older adults and other vulnerable groups: One goal 
of the workshop was to engage scientific journals in discussion given their important role in 
disseminating results. Both during the workshop and in formal comments to NIH following the 
workshop, the AGS highlighted the recent work emanating from the Reframing Aging 
Initiative undertaken by the Leaders of Aging Organizations (LAO, of which AGS is a 
member). The AGS also highlighted related changes made by the Journal of the American 
Geriatrics Society (JAGS) to its editorial policies.6 The Inclusion Across the Lifespan 
workshop summary made specific reference to the AGS position that describing individuals 
over 65 with terms such as “the elderly” could reinforce alienation, whereas terms like “older 
adults” were more likely to accomplish the important aim of building “increased respect and 
understanding.”3 
The companion piece in this issue by Lockett et al. highlights the impact of arbitrary age 
limits and condition-specific exclusions in previous NIH-funded phase III clinical trials to limit the 
available evidence base for the ten most common conditions impacting hospitalization or 
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disability among older adults. The analysis further reveals gaps in the current evidence base 
and opportunities for aging researchers to apply the new policy and develop more generalizable 
studies on behalf of older vulnerable populations. Further, the piece illustrates the difficulty in 
identifying published studies that were inclusive of older populations because of inconsistent 
definitions for the older adult study population in terms of both language and methods for 
reporting age.  
 
Workshop Recommendations Not Currently Addressed by the Policy 
It is notable that some recommendations from the workshop endorsed by the AGS were 
not addressed in the policy due to concerns from various stakeholder groups. Several key 
points were implied, but not specifically stated in the policy. For example, workshop attendees 
stressed that older adults should not simply be included in a token way, but that inclusion must 
be meaningful. In some instances, trials should solely focus on older adults (e.g., statins for 
primary prevention).9 Enrollment plans should use evidence-based strategies for recruitment 
and retention of older populations when applicable so that the health status of the study 
population mirrors that of persons living with the condition under study.10,11 Currently, the NIH 
will rely on reviewers and Scientific Review Officers to evaluate and promote these important 
aspects of inclusion of older adults in new applications. 
Workshop attendees further stressed to NIH that the peer-review research process 
needs to ensure appropriate aging research expertise on review panels assessing research 
designs and enrollment/retention plans for older adults. Finally, because the health and function 
of older adult populations remains heterogeneous at any given chronological age, workshop 
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participants encouraged the NIH to consider additional measures of health status such as gait 
speed, self-reported health, co-morbidity burden, or frailty indices. This is critical for readers to 
understand whether the health status of the study population mirrors the typical clinical 
population. The NIH is conducting discussions with various groups interested in functional 
outcomes, for example, with the National Advisory Board on Medical Rehabilitation Research. 
However, no standard functional measures have yet been adopted. Therefore, researchers will 
be able to continue including participants who are healthier, relatively speaking, than the target 
population despite including more older adults in clinical research. 
In addition, the importance of reporting age-related population characteristics in a 
consistent fashion in journal articles was considered. Consistency in reporting such information 
could facilitate summarizing the findings of multiple studies assessing important clinical 
questions and also help clinicians in assessing the relevance of study findings to the 
populations of patients for whom they provide care. However, concerns were raised about the 
challenges of achieving consensus regarding this issue among journal editors. AGS’s success 
(described below) influencing publication guidelines to use preferred terms when reporting 
research findings relevant to older adults may provide a foundation for additional efforts to 
impact reporting standards across the peer-reviewed literature.   
 
Future Directions and Opportunities for Academic Geriatrics  
At the time of the workshop, JAGS had just published an editorial outlining changes to 
author guidelines regarding the language about aging.6 The editorial stemmed from AGS 
engagement in the Reframing Aging initiative, undertaken by the LAO. With funding support 
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from a number of private foundations (AARP, Archstone Foundation, The Atlantic 
Philanthropies, Endowment for Health, Fan Fox and Leslie R. Samuels Foundation, The John A. 
Hartford Foundation, The Retirement Research Foundation, Rose Community Foundation, and 
The SCAN Foundation), the LAO engaged the FrameWorks Institute to gain a better 
understanding of how the language we currently use when describing older people has been 
heard by the public, media, and policy-makers, and to develop recommendations for how 
advocates could change that language to support better public understanding of our work.12 
With the JAGS editorial team, AGS had identified refining the language used when reporting the 
results of aging research as an important avenue for implementing the FrameWorks 
recommendations. As a result, JAGS identified preferred terms (“older adult” or “older people,” 
specifically) and instituted requirements for reporting age specificity when describing study 
participants in research findings in early 2017. These changes to editorial guidelines led by AGS 
were well-aligned with the workshop goal of engaging scientific journals to “consider 
opportunities for enhanced participation of these populations regardless of whether the research 
was funded by the NIH,”4 and the recommendations were subsequently included in the 
workshop report.3 
In addition to shaping discussions on changes to how research is conducted (described 
above), formal recognition of more inclusive terminology in the workshop report also offered an 
important “rising tide to lift all ships” in how research findings can be reported more dynamically. 
ClinicalTrials.gov, for example, has adjusted one of its age categories from “Seniors – 66+” to 
“Older Adults – 65+.” Since all NIH-funded clinical trials must be registered on Clinicaltrials.gov, 
there is potential for behavioral modification simply based on investigators aligning with the 
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verbiage used by the database. The AGS also has successfully advocated for changes to 
terminology and descriptors relevant to older people in the American Medical Association 
Manual of Style (see Table 1), and has made similar requests to editorial boards responsible for 
the American Psychological Association Publication Manual (see Table 2) and the Associated 
Press Stylebook (see Table 3). These critical resources set a base-line standard for how we 
report research findings, both in peer-reviewed journals and related news coverage. Effecting 
change here will be key to ensuring that the language we use when we talk about aging 
research helps policy-makers and the public understand the importance of research to 
improving how we all age.  
 
Policy Changes in Other Federal Agencies and Industry 
Workshop attendees recommended that the NIH Inclusion Across the Lifespan policy be 
adopted by all federal agencies. The Food and Drug Administration (FDA) convened a public 
meeting held April 16, 2018 entitled “Evaluating Inclusion and Exclusion Criteria in Clinical 
Trials.” Dr. Marie Bernard, NIA Deputy Director, presented highlights from the June 2017 NIH 
workshop. AGS was represented on the “Inclusion of Older Adults and Patients with Multiple 
Chronic Conditions” panel that addressed: What are the considerations for excluding elderly 
patients and patients with concomitant illness?; What are barriers to enrollment when there are 
not specific exclusions?; and What strategies can be used to enhance inclusion and increase 
enrollment? Materials from this public meeting are available at 
https://healthpolicy.duke.edu/events/evaluating-inclusion-and-exclusion-criteria-clinical-trials. No 
other agency changes are known to be undertaking a similar approach at this time. This work 
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builds upon previous engagement of AGS leaders with FDA.13 Substantial changes in 
pharmaceutical-industry practice will likely require revised FDA policies, but several large 
companies are developing new internal guidance and training materials to enhance inclusion of 
older adults.  
 
Opportunities for Academic Geriatrics 
The AGS believes the NIH Inclusion Across the Lifespan policy represents an 
opportunity for academic geriatrics in several domains consistent with the Future of Geriatric 
Medicine Task Force Recommendations.14 
1. Expansion of knowledge related to health in aging. The mandate for investigators to upload 
individual-level age data provides new opportunities for pre-planned and post-hoc meta-
analysis to examine age by treatment interactions in clinical trials, or important subgroup 
differences in observational studies. These may be fruitful areas where early investigators 
can obtain preliminary data or identify new focal points. 
2. Education across Disciplines. In order to implement this new policy effectively in studies of 
age-related conditions across health care, investigators, statisticians, and study staff outside 
gerontology/geriatrics will need additional training and support from researchers with 
relevant expertise. Table 4 suggests areas for geriatrics and gerontology researchers to 
develop educational materials and toolkits for dissemination across their institutions. Aging 
Centers could create a core service to review clinical studies prior to submission to optimize 
inclusion plans.  
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3. Advocacy for Older Adults. The Inclusion Across the Lifespan workshop emphasized the 
need for a paradigm shift from “protecting vulnerable subjects from research” to “protecting 
vulnerable subjects through research”. It is important that Institutional Review Board 
Members, researchers, and potential research subjects understand that underrepresenting 
older adults and those with multi-morbidity in clinical research results in potentially unsafe 
and inappropriate care decisions. The release of the NIH policy provides an opportunity for 
geriatrics researchers to advocate directly to these groups.  
4. Leadership. As institutions develop infrastructure and resources to respond to the new NIH 
policy, geriatrics researchers should advocate for leadership roles in such initiatives. This 
may include roles in IRBs, Clinical Translational Science Centers, or Clinical Research 
Units. Geriatrics Researchers should lead the charge not only in adopting more inclusive 
terminology and in reporting research findings, but also in advocating for systemic changes 
at the journal or manuscript-style standards level. 
 
Conclusion  
There is a vital need to include people of all ages in clinical trials for clinical and research 
reasons, but especially older adults. The new NIH policy on Inclusion Across the Lifespan, 
informed by AGS advocacy, is an exciting advance in the right direction. The policy for more 
representative inclusion is especially important for those in older ages, given the increasing 
prevalence of many diseases among the growing population of those over 65. The new policy 
helps in two specific ways: 1) to eliminate upper-age limits whenever possible for enrollment 
(without risk-justification) and 2) to change the language used to be more aligned with 
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Reframing Aging initiative of AGS when describing older adults. From a clinical perspective, in 
order to have evidence that applies to those who are most likely to live with chronic conditions, 
we must do better to enroll older adults in a meaningful way. From a research perspective, 
given that some diseases are far more likely to occur in older adults, including cancer and 
cardiovascular disease, we must make extra efforts to design studies that will specifically enroll 
those patients. AGS advocates that other policy improvements, not yet formally adopted, should 
also be pursued including the active recruitment of older adults, the inclusion of measures of 
function and/or frailty, and the use of specific review criteria to avoid “tokenism” by continuing 
the practice of including primarily healthier older adults that do not represent the typical older 
patient.  In the meantime, these additional policies must be pursued through review policies and 
practices during grant reviews. Finally, this gap between the adopted policy and the 
recommendations not adopted by NIH represent an advocacy opportunity for academic 
geriatricians from AGS to pursue in the coming months and years. 
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Table 1: Proposed Revisions to AMA Manual of Style 
CURRENT MANUAL AGS SUGGESTION 
Section 2: Style 
Chapter 11: Correct & Preferred Language 
11.5—Age and Sex Referents 
Use specific terminology to refer to persons' 
age. See also 11.10.3, Inclusive Language, 
Age. 
  
[. . .] 
  
Adults are persons aged 18 years and older 
and should be referred to as men or women. 
Persons 18 to 24 years of age may also be 
referred to as young adults. 
  
[. . .] 
Use specific terminology to refer to persons’ 
age. Whenever possible, include information 
about the age range, average age, and 
median age of the study population. See also 
11.10.3, Inclusive Language, Age. 
  
[. . . ] 
  
Age specificity (including age range, average 
age, and median age, if possible) is generally 
preferred on first reference to a study 
population.  On second reference, or when 
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referring to groups generally, adults are 
persons aged 18 years and older and should 
be referred to as men or women. Persons 18 
to 24 years of age may also be referred to as 
young adults. Persons 65-years-old and older 
may also be referred to as older people or 
older adults.  
  
[. . .] 
Section 2: Style 
Chapter 11: Correct & Preferred Language 
11.10.3—Age 
Discrimination based on age (young or old) is 
ageism. Because the term elderly connotes a 
stereotype, avoid using it as a noun. When 
referring to the entire population of elderly 
persons, use of the elderly may be 
appropriate (as in the impact of prescription 
drug costs on the elderly, for example). 
Otherwise, terms such as older persons, 
older people, elderly patients, geriatric 
patients, older adults, older patients, aging 
adults, persons 65 years and older, or the 
older population are preferred. 
  
Note: In studies that involve human beings, 
age should always be given specifically. 
Researchers in geriatrics may use defined 
terms for older age groups, eg, young-old 
(usually defined as 60 or 65 to 70 or so 
years) and old-old (80 years and older). See 
also 11.5, Age and Sex Referents. 
  
Adultism is a form of ageism in which children 
and adolescents are discounted. 
Discrimination based on age (young or old) is 
ageism. Because terms like seniors, elderly, 
the aged, aging dependents, old-old, young-
old, and similar “other-ing” terms connote a 
stereotype, avoid using them. Terms such as 
older persons, older people, older adults, 
older patients, older individuals, persons 65 
years and older, or the older population are 
preferred. 
  
Note: In studies that involve human beings, 
age should always be given specifically (e.g., 
“older people aged 75 to 84,” “older adults 
over age 65”). See also 11.5, Age and Sex 
Referents. 
  
Adultism is a form of ageism in which children 
and adolescents are discounted. 
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Table 2: Proposed Revisions to APA Publication Manual 
CURRENT COPY AGS SUGGESTION 
Chapter 3: Writing Clearly & Concisely 
General Guidelines for Reducing Bias 
Guideline 1: Describe at the Appropriate Level of Specificity 
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[. . .] 
 
To describe age groups, give a specific age 
range (“ages 65-83 years”) instead of a broad 
category (“over age 65”). 
 
[. . .] 
To describe age groups, give a specific age 
range (“ages 65-83 years”) instead of a broad 
category (“over age 65”). Additional 
information on age specificity (including 
average age and median age) should also be 
included whenever available. 
Chapter 3: Writing Clearly & Concisely 
General Guidelines for Reducing Bias 
Guideline 2: Be Sensitive to Labels 
Respect people’s preferences; call people 
what they prefer to be called. Accept that 
preferences change with time and that 
individuals within groups often disagree about 
the designations they prefer. Make an effort 
to determine what is appropriate for your 
situation; you may need to ask your 
participants which designations they prefer, 
particularly when preferred designations are 
being debated within groups. 
 
Avoid labeling people when possible. A 
common occurrence in scientific writing is 
that participants in a study tend to lose their 
individuality; they are broadly categorized as 
objects (noun forms such as the gays and the 
elderly) or, particularly in descriptions of 
people with disabilities, are equated with their 
conditions—the amnesiacs, the depressives, 
the schizophrenics, the LDs, for example. 
One solution is to use adjectival forms (e.g., 
“gay men,” “older adults,” “amnesic patients”). 
Another is to “put the person first,” followed 
by a descriptive phrase (e.g., “people 
diagnosed with schizophrenia”). Note that the 
latter solution is preferred when describing 
people with disabilities. 
 
[. . .] 
Avoid labeling people. A common occurrence 
in scientific writing is that participants in a 
study tend to lose their individuality; they are 
broadly categorized as objects (noun forms 
such as the gays and the elderly) or, 
particularly in descriptions of people with 
disabilities, are equated with their 
conditions—the amnesiacs, the depressives, 
the schizophrenics, the LDs, for example.  
 
On first reference to a group of older people, 
be as specific as possible by including age 
range, average age, and median age, where 
available.  Because terms like seniors, 
elderly, the aged, aging dependents, old-old, 
young-old, and similar “other-ing” terms 
connote a stereotype, avoid using them. 
Terms such as older persons, older people, 
older adults, older patients, older individuals, 
persons 65 years and older, or the older 
population are preferred. 
 
Additionally—particularly when describing 
people with disabilities or those who live with 
specific health conditions, practice “putting 
the person first,” followed by a descriptive 
phrase (e.g., “older people diagnosed with 
schizophrenia”). 
Chapter 3: Writing Clearly & Concisely 
Reducing Bias by Topic 
3.16: Age 
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Age should be reported as part of the 
description of participants in the Method 
section. Be specific in providing age ranges; 
avoid open-ended definitions such as “under 
18 years” or “over 65 years.” 
 
[. . .] 
 
The terms elderly and senior are not 
acceptable as nouns; boomer or baby 
boomer should not be used unless they are 
related to a study on this topic. The term 
older adult is preferred. Age groups may also 
be described with adjectives. Gerontologists 
may prefer to use combination terms for older 
age groups (young-old, old-old, very old, 
oldest old, and centenarians); provide the 
specific ages of these groups and use them 
only as adjectives. 
Age (including age range, average age, and 
median age) should be reported as part of 
the description of participants in the Methods 
section.  Be specific in providing age ranges; 
avoid open-ended definitions such as “over 
65 years.” 
 
[. . .] 
 
Because terms like seniors, elderly, the aged, 
aging dependents, old-old, young-old, very 
old, oldest old, and similar “other-ing” terms 
connote a stereotype, avoid using them. 
Terms such as older persons, older people, 
older adults, older patients, older individuals, 
persons 65 years and older, or the older 
population are preferred. 
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Table 3: Proposed Revisions to AP Stylebook 
CURRENT COPY AGS SUGGESTION 
Ages 
Use when deemed relevant to the situation. If 
someone is quoted as saying, I’m too old to 
get another job, the age is relevant. 
Generally, use ages for profiles, obituaries, 
significant career milestones and 
achievements unusual for the age. Use ages 
for people commenting or providing 
information only if their age is relevant to their 
comments (e.g., a teenager’s comment on 
video games aimed at that age group). 
Appropriate background, such as a parent of 
two young children or a World War II veteran, 
may suffice instead of actual age. 
 
Always use figures. The girl is 15 years old; 
the law is 8 years old; the 101-year-old 
house. When the context does not require 
years or years old, the figure is presumed to 
be years. 
 
Use hyphens for ages expressed as 
adjectives before a noun or as substitutes for 
a noun. 
 
Examples: A 5-year-old boy, but the boy is 5 
years old. The boy, 7, has a sister, 10. The 
woman, 26, has a daughter 2 months old. 
The race is for 3-year-olds. The woman is in 
her 30s (no apostrophe). 
 
See also boy, girl, infant, youth, numerals, 
and elderly. 
Use when deemed relevant to the situation. If 
someone is quoted as saying, I’m too old to 
get another job, the age is relevant. 
Generally, use ages for profiles, obituaries, 
significant career milestones and 
achievements unusual for the age. Use ages 
for people commenting or providing 
information only if their age is relevant to their 
comments (e.g., a teenager’s comment on 
video games aimed at that age group, a 
health recommendation based on a study of 
women in their 80s). Appropriate background, 
such as a parent of two young children or a 
World War II veteran, may suffice instead of 
actual age. 
 
Always use figures. The girl is 15 years old; 
the law is 8 years old; the 101-year-old 
house. When the context does not require 
years or years old, the figure is presumed to 
be years. 
 
Use hyphens for ages expressed as 
adjectives before a noun or as substitutes for 
a noun. 
 
Examples: A 5-year-old boy, but the boy is 5 
years old. The boy, 7, has a sister, 10. The 
woman, 26, has a daughter 2 months old. 
The race is for 3-year-olds. The woman is in 
her 30s (no apostrophe). 
 
See also boy, girl, infant, youth, numerals, 
and older adult. 
 
 
This article is protected by copyright. All rights reserved.
 Inclusion Across the Lifespan 
CURRENT COPY AGS SUGGESTION 
 
Elderly 
Use this word carefully and sparingly. Do not 
refer to a person as elderly unless it is clearly 
relevant to the story. Apply the same principle 
to terms such as senior citizen. 
 
It is appropriate in generic phrases that do 
not refer to specific individuals: concern for 
the elderly, a home for the elderly, etc. 
 
If the intent is to show that an individual’s 
faculties have deteriorated, cite a graphic 
example and give attribution for it.  Use age 
when available and appropriate. 
 
 
An outdated term for older individuals. Use 
older adult(s) or older person/people instead. 
 
If the intent is to show that an individual’s 
faculties have deteriorated, cite a graphic 
example and give attribution for it.  Use age 
when available and appropriate, especially 
when reporting on research or 
recommendations for a specific subset of the 
population. Example: The researchers found 
that weekly exercise decreased the risk of 
diabetes among older adults in their 70s and 
80s. 
 
See older adult. 
Older Adult [Proposed Addition] 
N/A The preferred term for a person or people 65-
years-old or older. 
Senior Citizen 
Use the term sparingly. See elderly. An outdated term for older people. Use older 
adult(s) or older person/people instead. See 
older adult. 
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Table 4: Educational needs of investigators and study staff on Inclusion Plans that can 
be addressed by Geriatrics Researchers 
Topic Learning Objectives 
Evidence 
Based 
Practices for 
Participant 
Recruitment, 
Consent/Assent 
1. Use of purposeful recruitment, and working with stakeholders to 
understand potential barriers to recruitment and retention 
2. Use of proactive recruitment strategies, including engaging the 
communities  
3. Assessing capacity to provide informed consent, inclusion of Legally 
Authorized Representatives 
Study Design 1. Strategies to remove logistical barriers (transportation, mobility, sensory 
impairment) 
2. Minimize acceptable criteria to balance scientific justification vs. 
generalizability 
3. Use of alternative study designs to allow for greater inclusion: adaptive 
trials (i.e., sequential, multiple assignment, randomized trials); platform 
trials (flexible features, such as dropping treatments for futility, declaring 
one or more treatments superior, or adding new treatments to be tested 
during the course of a trial); preference designs; pragmatic trials  
Data Collection, 
Analysis, and 
Reporting 
1. Multivariable risk-based analytic methods needed to address 
heterogeneity 
2. Choosing analytic strategies to maximize the potential knowledge gained 
from preplanned subgroups or stratified recruitment 
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